Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
June 2, 2015
Patent Application Number
10535472
Date Filed
November 18, 2003
Patent Citations Received
Patent Primary Examiner
Patent abstract
A novel class of pharmaceuticals which comprises a Locked Nucleic Acid (LNA) which can be used in antisense therapy. These novel oligonucleotides have improved antisense properties. The novel oligonucleotides are composed of at least one LNA selected from beta-D-thio/amino-LNA or alpha-L-oxy/thio/amino-LNA. The oligonucleotides comprising LNA may also include DNA and/or RNA nucleotides.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
